ATE231721T1 - Verwendung von tropolon derivate zur hemmung des inositmono phosphatase - Google Patents

Verwendung von tropolon derivate zur hemmung des inositmono phosphatase

Info

Publication number
ATE231721T1
ATE231721T1 AT96916132T AT96916132T ATE231721T1 AT E231721 T1 ATE231721 T1 AT E231721T1 AT 96916132 T AT96916132 T AT 96916132T AT 96916132 T AT96916132 T AT 96916132T AT E231721 T1 ATE231721 T1 AT E231721T1
Authority
AT
Austria
Prior art keywords
inositemono
phosphatase
inhibit
tropolone derivatives
tropolone
Prior art date
Application number
AT96916132T
Other languages
English (en)
Inventor
Khalid Islam
Stefania Stefanelli
Federica Sponga
Maurizio Denaro
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of ATE231721T1 publication Critical patent/ATE231721T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT96916132T 1995-05-24 1996-05-20 Verwendung von tropolon derivate zur hemmung des inositmono phosphatase ATE231721T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95107936 1995-05-24
PCT/EP1996/002160 WO1996037197A1 (en) 1995-05-24 1996-05-20 Use of tropolone derivatives as inhibitors of the enzyme inositol monophosphatase

Publications (1)

Publication Number Publication Date
ATE231721T1 true ATE231721T1 (de) 2003-02-15

Family

ID=8219287

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96916132T ATE231721T1 (de) 1995-05-24 1996-05-20 Verwendung von tropolon derivate zur hemmung des inositmono phosphatase

Country Status (13)

Country Link
US (1) US5990160A (de)
EP (1) EP0828483B1 (de)
JP (1) JP4054061B2 (de)
KR (2) KR20040004513A (de)
AT (1) ATE231721T1 (de)
AU (1) AU698059B2 (de)
CA (1) CA2221771C (de)
DE (1) DE69626010T2 (de)
DK (1) DK0828483T3 (de)
ES (1) ES2186782T3 (de)
PT (1) PT828483E (de)
SI (1) SI0828483T1 (de)
WO (1) WO1996037197A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6689342B1 (en) * 2002-07-29 2004-02-10 Warner-Lambert Company Oral care compositions comprising tropolone compounds and essential oils and methods of using the same
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56147704A (en) * 1980-04-07 1981-11-16 Rowaale Keshohin Kk Dermatological composition
US4981980A (en) * 1989-09-14 1991-01-01 Merck & Co., Inc. Drug for treating manic depression

Also Published As

Publication number Publication date
ES2186782T3 (es) 2003-05-16
EP0828483B1 (de) 2003-01-29
PT828483E (pt) 2003-06-30
JPH11505817A (ja) 1999-05-25
WO1996037197A1 (en) 1996-11-28
KR100412753B1 (ko) 2004-04-21
AU5900096A (en) 1996-12-11
KR20040004513A (ko) 2004-01-13
DK0828483T3 (da) 2003-05-19
DE69626010T2 (de) 2003-07-24
EP0828483A1 (de) 1998-03-18
DE69626010D1 (de) 2003-03-06
SI0828483T1 (en) 2003-06-30
US5990160A (en) 1999-11-23
JP4054061B2 (ja) 2008-02-27
CA2221771A1 (en) 1996-11-28
KR19990021882A (ko) 1999-03-25
AU698059B2 (en) 1998-10-22
CA2221771C (en) 2007-09-18

Similar Documents

Publication Publication Date Title
NZ335981A (en) Ketobenzamides as calpain inhibitors
ATE241358T1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
BG102071A (en) Minor molecule inhibitors of rotamase enzymic activity
DE69837295D1 (de) Probucolbernsteinsäureester zur Hemmung der Expression von VCAM-1
DE69728594D1 (de) Chromfreie Zusammensetzung zur Behandlung von Metalloberflächen
EA199900194A1 (ru) Реминерализующая композиция
DK0755249T3 (da) Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom
DK0705100T3 (da) Terapeutiske substituerede guanidiner
MX9300777A (es) Derivados aminoacetilmercapto novedosos utiles como inhibidores de la encefalinasa y la eca
PT871454E (pt) Inibidores fosforosos que contem protease de cisteina e de serina
DE69333931D1 (de) Verwendung von Krillenzymen zur Behandlung von Zahnbelag
BG99177A (en) New 7 -substituted-4-aza-5 - cholestanones as inhibitors of 5 - reductase
DE60013098D1 (de) Zusammensetzung zur hautdesinfizierung
ATE321548T1 (de) Verwendung von statin zur behandlung von hauterkrankungen
DE69635114D1 (de) Proteinfarnesyltransferase-inhibitoren in kombination mit hmgcoa-reduktase-inhibitoren zur behandlung von aids
WO1997008934A3 (en) Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
ATE231721T1 (de) Verwendung von tropolon derivate zur hemmung des inositmono phosphatase
ZA9711468B (en) New use of comt inhibitors
ES2070134T3 (es) Inhibidores de lisil oxidasa.
DE69429013D1 (de) Verwendung von dimeticon zur behandlung der konstipation
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
DE69732784D1 (de) Inhibierung von invasiver remodulierung
ATE255822T1 (de) Verwendung von sauren natriumpolyphosphaten zur keimhemmung von schimmel und hefen
DE69901104D1 (de) Verwendung von mikroorganismen extrakten in kosmetischen oder pharmazeutischen zusammensetzungen
NO984964L (no) Anvendelse av fosfonsyreestere for behandling av funksjonelle forstyrrelser i hjernen og ved depresjon

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0828483

Country of ref document: EP